Oui, le stress chronique peut contribuer à des troubles neurologiques et affecter le noyau rouge.
Stress chroniqueRisqueTroubles neurologiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Noyau rouge : Questions médicales les plus fréquentes",
"headline": "Noyau rouge : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Noyau rouge : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-03",
"dateModified": "2026-04-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Noyau rouge"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tegmentum du mésencéphale",
"url": "https://questionsmedicales.fr/mesh/D013681",
"about": {
"@type": "MedicalCondition",
"name": "Tegmentum du mésencéphale",
"code": {
"@type": "MedicalCode",
"code": "D013681",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.132.659.413.875"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Noyau rouge",
"alternateName": "Red Nucleus",
"code": {
"@type": "MedicalCode",
"code": "D012012",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Qing-Qing Yang",
"url": "https://questionsmedicales.fr/author/Qing-Qing%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Department of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi, China; Department of Pathogenic Biology and Immunology, Xi'an Jiaotong University Health Science Center, Xi'an 710061, Shaanxi, China."
}
},
{
"@type": "Person",
"name": "Jun-Yang Wang",
"url": "https://questionsmedicales.fr/author/Jun-Yang%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathogenic Biology and Immunology, Xi'an Jiaotong University Health Science Center, Xi'an 710061, Shaanxi, China. Electronic address: jywang@mail.xjtu.edu.cn."
}
},
{
"@type": "Person",
"name": "Xue Tian",
"url": "https://questionsmedicales.fr/author/Xue%20Tian",
"affiliation": {
"@type": "Organization",
"name": "Department of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi, China; Department of Pathogenic Biology and Immunology, Xi'an Jiaotong University Health Science Center, Xi'an 710061, Shaanxi, China; Shaanxi Blood Center, Xi'an 710061, Shaanxi, China."
}
},
{
"@type": "Person",
"name": "Xiao-Yan Zeng",
"url": "https://questionsmedicales.fr/author/Xiao-Yan%20Zeng",
"affiliation": {
"@type": "Organization",
"name": "Department of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China."
}
},
{
"@type": "Person",
"name": "Lan Kong",
"url": "https://questionsmedicales.fr/author/Lan%20Kong",
"affiliation": {
"@type": "Organization",
"name": "Department of Public Health Sciences, The Pennsylvania State University College of Medicine and Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033-0850, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Projected pooling loss for red nucleus segmentation with soft topology constraints.",
"datePublished": "2024-07-09",
"url": "https://questionsmedicales.fr/article/38988992",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1117/1.JMI.11.4.044002"
}
},
{
"@type": "ScholarlyArticle",
"name": "The brainstem's red nucleus was evolutionarily upgraded to support goal-directed action.",
"datePublished": "2024-01-01",
"url": "https://questionsmedicales.fr/article/38260662",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1101/2023.12.30.573730"
}
},
{
"@type": "ScholarlyArticle",
"name": "Phylogenetic reduction of the magnocellular red nucleus in primates and inter-subject variability in humans.",
"datePublished": "2024-03-13",
"url": "https://questionsmedicales.fr/article/38550712",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fnana.2024.1331305"
}
},
{
"@type": "ScholarlyArticle",
"name": "Compensatory Hyperactivity of the Ipsilesional Red Nucleus in a Patient With Somatosensory Cortex Damage: A Case Report.",
"datePublished": "2023-11-06",
"url": "https://questionsmedicales.fr/article/38047094",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.12786/bn.2023.16.e33"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of emotional and behavioral problems with the development of the substantia nigra, subthalamic nucleus, and red nucleus volumes and asymmetries from childhood to adolescence: A longitudinal cohort study.",
"datePublished": "2024-02-26",
"url": "https://questionsmedicales.fr/article/38403656",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41398-024-02803-4"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009420"
},
{
"@type": "ListItem",
"position": 3,
"name": "Système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D002490"
},
{
"@type": "ListItem",
"position": 4,
"name": "Encéphale",
"item": "https://questionsmedicales.fr/mesh/D001921"
},
{
"@type": "ListItem",
"position": 5,
"name": "Tronc cérébral",
"item": "https://questionsmedicales.fr/mesh/D001933"
},
{
"@type": "ListItem",
"position": 6,
"name": "Mésencéphale",
"item": "https://questionsmedicales.fr/mesh/D008636"
},
{
"@type": "ListItem",
"position": 7,
"name": "Pédoncule cérébral",
"item": "https://questionsmedicales.fr/mesh/D065850"
},
{
"@type": "ListItem",
"position": 8,
"name": "Tegmentum du mésencéphale",
"item": "https://questionsmedicales.fr/mesh/D013681"
},
{
"@type": "ListItem",
"position": 9,
"name": "Noyau rouge",
"item": "https://questionsmedicales.fr/mesh/D012012"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Noyau rouge - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Noyau rouge",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Noyau rouge",
"description": "Comment diagnostiquer une dysfonction du noyau rouge ?\nQuels tests sont utilisés pour évaluer le noyau rouge ?\nQuels signes neurologiques indiquent une atteinte du noyau rouge ?\nLe noyau rouge peut-il être affecté par des AVC ?\nQuels examens complémentaires sont recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D012012#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Noyau rouge",
"description": "Quels sont les symptômes d'une lésion du noyau rouge ?\nComment se manifeste une hypertonie liée au noyau rouge ?\nLes troubles de la coordination sont-ils liés au noyau rouge ?\nPeut-on observer des réflexes anormaux ?\nLes tremblements sont-ils fréquents avec une dysfonction du noyau rouge ?",
"url": "https://questionsmedicales.fr/mesh/D012012#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Noyau rouge",
"description": "Peut-on prévenir les troubles du noyau rouge ?\nQuels facteurs de risque sont associés aux troubles du noyau rouge ?\nL'exercice physique peut-il aider à prévenir les troubles ?\nComment la nutrition influence-t-elle la santé du noyau rouge ?\nLe stress a-t-il un impact sur le noyau rouge ?",
"url": "https://questionsmedicales.fr/mesh/D012012#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Noyau rouge",
"description": "Quels traitements sont disponibles pour les troubles du noyau rouge ?\nLa chirurgie est-elle une option pour les troubles du noyau rouge ?\nLes médicaments peuvent-ils aider à réduire les symptômes ?\nLa thérapie physique est-elle bénéfique ?\nQuels médicaments sont souvent prescrits pour les tremblements ?",
"url": "https://questionsmedicales.fr/mesh/D012012#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Noyau rouge",
"description": "Quelles complications peuvent survenir avec une lésion du noyau rouge ?\nLes troubles cognitifs sont-ils possibles ?\nComment les troubles du noyau rouge affectent-ils la qualité de vie ?\nLes complications peuvent-elles être réversibles ?\nY a-t-il un risque accru de chutes ?",
"url": "https://questionsmedicales.fr/mesh/D012012#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Noyau rouge",
"description": "Quels sont les principaux facteurs de risque pour les troubles du noyau rouge ?\nL'âge influence-t-il le risque de troubles du noyau rouge ?\nLe mode de vie peut-il affecter le risque ?\nLes maladies cardiovasculaires sont-elles un facteur de risque ?\nLe stress chronique est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D012012#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction du noyau rouge ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen neurologique et des imageries cérébrales comme l'IRM sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer le noyau rouge ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie et des évaluations fonctionnelles des mouvements sont effectués."
}
},
{
"@type": "Question",
"name": "Quels signes neurologiques indiquent une atteinte du noyau rouge ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tremblements, une rigidité musculaire et des troubles de la coordination peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Le noyau rouge peut-il être affecté par des AVC ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un AVC peut endommager le noyau rouge, entraînant des troubles moteurs."
}
},
{
"@type": "Question",
"name": "Quels examens complémentaires sont recommandés ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des électromyogrammes et des tests de conduction nerveuse peuvent être utiles."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une lésion du noyau rouge ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des tremblements, une ataxie et des mouvements involontaires."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une hypertonie liée au noyau rouge ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypertonie se manifeste par une rigidité accrue des muscles et une résistance au mouvement."
}
},
{
"@type": "Question",
"name": "Les troubles de la coordination sont-ils liés au noyau rouge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le noyau rouge joue un rôle clé dans la coordination des mouvements volontaires."
}
},
{
"@type": "Question",
"name": "Peut-on observer des réflexes anormaux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réflexes exagérés ou diminués peuvent indiquer une atteinte du noyau rouge."
}
},
{
"@type": "Question",
"name": "Les tremblements sont-ils fréquents avec une dysfonction du noyau rouge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tremblements sont un symptôme courant de dysfonctionnement du noyau rouge."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles du noyau rouge ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par un mode de vie sain et la gestion des facteurs de risque neurologiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés aux troubles du noyau rouge ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'AVC, les maladies neurodégénératives et les traumatismes crâniens sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'exercice physique peut-il aider à prévenir les troubles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la santé neurologique et réduire les risques."
}
},
{
"@type": "Question",
"name": "Comment la nutrition influence-t-elle la santé du noyau rouge ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé cérébrale et réduire les risques neurologiques."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur le noyau rouge ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la fonction neurologique et aggraver les symptômes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles du noyau rouge ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la rééducation, la physiothérapie et parfois des médicaments."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option pour les troubles du noyau rouge ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, la chirurgie peut être envisagée pour traiter des lésions spécifiques."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à réduire les symptômes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments comme les antiparkinsoniens peuvent aider à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "La thérapie physique est-elle bénéfique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie physique aide à améliorer la coordination et la force musculaire."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont souvent prescrits pour les tremblements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des bêta-bloquants et des anticonvulsivants sont souvent utilisés pour les tremblements."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une lésion du noyau rouge ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles moteurs sévères et des problèmes d'équilibre."
}
},
{
"@type": "Question",
"name": "Les troubles cognitifs sont-ils possibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles cognitifs peuvent survenir en raison de l'impact sur le système nerveux central."
}
},
{
"@type": "Question",
"name": "Comment les troubles du noyau rouge affectent-ils la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent réduire l'autonomie, affecter les activités quotidiennes et provoquer des douleurs."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être atténuées avec un traitement précoce et approprié."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de chutes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles de l'équilibre augmentent le risque de chutes chez les patients affectés."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour les troubles du noyau rouge ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, les maladies neurodégénératives et les traumatismes sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de troubles du noyau rouge ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, en particulier pour les maladies neurodégénératives."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il affecter le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les maladies cardiovasculaires sont-elles un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies cardiovasculaires peuvent augmenter le risque de troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Le stress chronique est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à des troubles neurologiques et affecter le noyau rouge."
}
}
]
}
]
}
Department of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi, China; Department of Pathogenic Biology and Immunology, Xi'an Jiaotong University Health Science Center, Xi'an 710061, Shaanxi, China.
Department of Pathogenic Biology and Immunology, Xi'an Jiaotong University Health Science Center, Xi'an 710061, Shaanxi, China. Electronic address: jywang@mail.xjtu.edu.cn.
Department of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi, China; Department of Pathogenic Biology and Immunology, Xi'an Jiaotong University Health Science Center, Xi'an 710061, Shaanxi, China; Shaanxi Blood Center, Xi'an 710061, Shaanxi, China.
Department of Public Health Sciences, The Pennsylvania State University College of Medicine and Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033-0850, USA.
Department of Neurology, The Pennsylvania State University College of Medicine and Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033-0850, USA.
Department of Neurology, The Pennsylvania State University College of Medicine and Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033-0850, USA.
Department of Pharmacology, The Pennsylvania State University College of Medicine and Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033-0850, USA.
Department of Neurology, The Pennsylvania State University College of Medicine and Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033-0850, USA.
Department of Pharmacology, The Pennsylvania State University College of Medicine and Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033-0850, USA.
Department of Radiology, The Pennsylvania State University College of Medicine and Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033-0850, USA.
Deep learning is the standard for medical image segmentation. However, it may encounter difficulties when the training set is small. Also, it may generate anatomically aberrant segmentations. Anatomic...
This new loss function introduces soft constraints on the topology by magnifying small parts of the structure to segment to avoid that they are discarded in the segmentation process. To that purpose, ...
When applied to the segmentation of the red nucleus from QSM data, the approach led to a very high accuracy (Dice 89.9%) and no topological errors. Moreover, the proposed loss function improved the Di...
We propose an effective method to automatically segment the red nucleus which is based on a new loss for introducing topology constraints in deep learning segmentation....
The red nucleus is a large brainstem structure that coordinates limb movement for locomotion in quadrupedal animals (Basile et al., 2021). The humans red nucleus has a different pattern of anatomical ...
The red nucleus is part of the motor system controlling limb movements. While this seems to be a function common in many vertebrates, its organization and circuitry have undergone massive changes duri...
We therefore mapped the red nucleus in cytoarchitectonic sections of 20 primate species belonging to 5 primate groups including prosimians, new world monkeys, old world monkeys, non-human apes and hum...
We created openly available high-resolution cytoarchitectonic delineations of the human red nucleus in the microscopic BigBrain model and human probabilistic maps that capture inter-subject variations...
That is, the red nucleus has transformed from a magnocellular-dominated to a parvocellular-dominated station. It is reasonable to assume that these changes are intertwined with evolutionary developmen...
This case study describes a patient who experienced motor recovery and involuntary movements following damage to the right primary somatosensory cortex caused by an intracranial hemorrhage. The patien...
The substantia nigra (SN), subthalamic nucleus (STN), and red nucleus (RN) have been widely studied as important biomarkers of degenerative diseases. However, how they develop in childhood and adolesc...
The substantia nigra pars compacta (SNc) is the key pathologic locus in neurodegenerative parkinsonian disorders. Recently, in vivo susceptibility MRI metrics were associated with postmortem glial cel...
In vivo MRI and postmortem data were obtained from 34 parkinsonism subjects and 3 controls. Neuron density, glial cell density, and percentages of area occupied by α-synuclein and tau were quantified ...
The RN had greater neuron (t...
The RN is resilient to parkinsonian-related pathological processes compared to the SNc, and susceptibility MRI captured glial cell density in both regions. These findings help to further our understan...
Cytoarchitectural staining is of great importance in disease diagnosis and cell biology research. This study developed user-friendly multifunctional red-emissive carbon dots (R-CDs) for rapid cell nuc...
Our previous study has identified that glutamate in the red nucleus (RN) facilitates the development of neuropathic pain through metabotropic glutamate receptors (mGluR). Here, we further explored the...
Our previous study has verified that activation of group Ⅰ metabotropic glutamate receptors (mGluRⅠ) in the red nucleus (RN) facilitate the development of neuropathological pain. Here, we further disc...
The nucleus of the solitary tract (NTS) receives direct viscerosensory vagal afferent input that drives autonomic reflexes, neuroendocrine function and modulates behaviour. A subpopulation of NTS neur...